| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2083144 | Drug Discovery Today: Therapeutic Strategies | 2006 | 6 Pages |
Abstract
Despite important advances being made in the treatment of chronic hepatitis B (CHB), complete eradication of hepatitis B virus has remained elusive with the current available therapies. Future treatment for CHB is likely to include drugs with more potent antiviral activity targeting different stages of the viral replication cycle and the host response to CHB. Furthermore, combination therapy might prove to be an important aspect in CHB treatment with the availability of newer drugs.
Section editors:Gary Woodnutt – CovX, San Diego, USA.Paul-Henri Lambert – Centre of Vaccinology, University of Geneva, Switzerland.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
James Fung, Ching-Lung Lai, Man-Fung Yuen,